Bruker Q1 2024 Adj EPS $0.53 Beats $0.46 Estimate, Sales $721.700M Miss $729.879M Estimate
Portfolio Pulse from Benzinga Newsdesk
Bruker Corporation (NASDAQ:BRKR) reported Q1 2024 adjusted EPS of $0.53, surpassing the $0.46 estimate, marking a 15.22% beat but a 17.19% decrease from the previous year's $0.64. Sales reached $721.7M, missing the $729.879M estimate by 1.12%, yet showing a 5.31% increase from last year's $685.3M.
May 02, 2024 | 11:04 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bruker Corporation reported a mixed Q1 2024 with EPS beating estimates but sales missing expectations. Adjusted EPS was $0.53, above the $0.46 estimate, while sales were $721.7M, below the $729.879M forecast.
Bruker's EPS beat suggests operational efficiency and profitability that could appeal to investors, potentially offsetting the slight miss in sales. The mixed results present a neutral short-term outlook for BRKR's stock price, as the positive earnings surprise could balance concerns over the sales miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100